Andrea T. Franson

This study shows that inhibiting ATM signaling with AZD1390 improves radiation efficacy in H3K27M-altered diffuse midline glioma by enhancing DNA damage repair sensitivity.

This paper evaluates how high-dose DFMO affects protein translation in neuroblastoma, showing it inhibits translation at high doses but not low doses, suggesting potential for higher-dose therapies.

This paper develops a single-molecule system to detect and monitor plasma nucleosomes and oncoproteins in Diffuse Midline Glioma patients, showing clinical utility for non-invasive diagnostics.